301060 兰卫医学
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)0.060-7.36834.02914.6279.187
总资产报酬率 ROA (%)0.036-4.20521.09711.3977.690
投入资产回报率 ROIC (%)0.050-6.18830.49014.1529.114

边际利润分析
销售毛利率 (%)21.90520.80142.63638.23232.292
营业利润率 (%)0.623-8.11222.60617.93514.413
息税前利润/营业总收入 (%)0.396-8.94621.72017.94313.052
净利润/营业总收入 (%)-0.061-9.65817.59914.71110.861

收益指标分析
经营活动净收益/利润总额(%)1,118.7507.078124.74599.158107.815
价值变动净收益/利润总额(%)-9.5611.3830.2673.1984.566
营业外收支净额/利润总额(%)-17.34811.367-4.957-0.288-9.955

偿债能力分析
流动比率 (X)3.0292.8272.3974.2795.747
速动比率 (X)2.5772.3812.1133.9415.072
资产负债率 (%)31.67933.70439.34322.1170.152
带息债务/全部投入资本 (%)15.93916.07211.8621.3600.995
股东权益/带息债务 (%)516.742511.272721.9207,018.7429,903.254
股东权益/负债合计 (%)193.694176.847139.966336.060545.334
利息保障倍数 (X)-2.914-43.468119.390303.208-229.626

营运能力分析
应收账款周转天数 (天)210.694347.656129.355132.613140.101
存货周转天数 (天)92.651104.41340.42246.96068.879